The Pentagon announced Monday the US Army had awarded Pfizer a $3.5 billion contract to manufacture 500 million doses of its COVID-19 vaccine by the end of 2022 for distribution around the world. Last month, Pfizer announced that the latest batch of 200 million doses would be delivered between October of this year and April of 2022.
In June, Pfizer and Germany-based BioNTech announced that they would provide 500 million doses “at a not-for-profit price” to the feds for distribution to more than 100 countries around the world, most of them in Africa.
“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,” Pfizer Chairman and CEO Albert Bourla said at the time. “COVID-19 has impacted everyone, everywhere, and to win the battle against this pandemic, we must ensure expedited access to vaccines for all.”
The two-shot Pfizer-BioNTech vaccine is one of three approved only on an emergency basis by the Food and Drug Administration (FDA).